Showing 3391-3400 of 4063 results for "".
- BVI Announces Certification for its IOL Portfolio Under the European Medical Device Regulationhttps://modernod.com/news/bvi-announces-certification-for-its-iol-portfolio-under-the-european-medical-device-regulation/2481094/BVI announced certification for its IOL portfolio under the European Medical Device Regulation (MDR, (EU) 2017/745) from its Notified Body, the British Standards Institution (BSI)¹. The new regulatory criteria came into effect in May 2021, replacing the prior Medica
- Rayner to Announce Launch of RayPRO+ Digital Health Platform at the ESCRShttps://modernod.com/news/rayner-to-announce-launch-of-raypro-digital-health-platform-at-the-escrs/2481082/Rayner announced the global launch of RayPRO+ at the upcoming ESCRS 2022 congress in Milan. RayPRO is Rayner’s proprietary mobile app and web-based digital platform that proactively collects a blend of patient reported outcomes (PROs) over 3 years. RayPRO+ has the added ability to
- ESCRS Launches New Awards Program to Foster Digital Transformationhttps://modernod.com/news/escrs-launches-new-awards-program-to-foster-digital-transformation/2481078/The European Society of Cataract & Refractive Surgeons (ESCRS) announced the launch of the 2022 ESCRS Digital Research Awards (DRA), an initiative sponsored by the society to support and encourage innovative research that leads to digital transformation in the fields of cataract, re
- California Legislature Passes Optometric Surgery Billhttps://modernod.com/news/california-legislature-passes-optometric-surgery-bill/2481077/The California Legislature recently passed AC 2236, an optometric surgery bill that, if signed into law, would expand optometrists’ scope of practice in California to include some scalpel and
- Himalayan Cataract Project Appoints Katherine G. Overbey as CEOhttps://modernod.com/news/himalayan-cataract-project-appoints-katherine-g-overbey-as-ceo/2481070/The Himalayan Cataract Project (HCP) has named Katherine G. Overbey (K-T) its new Chief Executive Officer, effective as of October 4, 2022. As HCP enters its 28th year, HCP’s Board of Directors anticipates that Ms. Overbey will guide the organization in its mission to c
- Lensar Announces Application for Certification of the ALLY Adaptive Cataract Treatment System in the EUhttps://modernod.com/news/lensar-announces-application-for-certification-of-the-ally-adaptive-cataract-treatment-system-in-the-eu/2481069/Lensar announced the application for certification of the ALLY Adaptive Cataract Treatment System in the European Union. “Following the FDA clearance of ALLY in June 2022 and recent US commercial launch, this is another important step in our effort to bring ALLY to
- Alimera Announces Multiple Abstracts Highlighting ILUVIEN Real-World Data at EURETINA Annual Congresshttps://modernod.com/news/alimera-announces-multiple-abstracts-highlighting-iluvien-real-world-data-at-euretina-annual-congress/2481055/Alimera Sciences announced that clinical data for ILUVIEN (fluocinolone acetonide intravitreal implant 0.19mg) will be featured in more than 20 scientific abstracts during the EURETINA 2022 congress being held in Hamburg, Germany from September 1-4, 2022. Audio Na
- Zeiss Integrated Workflow Solutions Designed to Create Digital Transformation in Health Carehttps://modernod.com/news/zeiss-integrated-workflow-solutions-are-creating-the-digital-transformation-in-health-care/2481054/At Zeiss Innovation Week, taking place September 6-8, 2022, Zeiss Medical Technology will host experts in ophthalmology to share their personal experiences of how the power of integrated workflow solutions, data management, and a range of new software applications enable improved efficiencies and
- Bausch Health Continuing Process Toward Separating Bausch + Lombhttps://modernod.com/news/bausch-health-continuing-process-toward-separating-bausch-lomb/2481048/Bausch Health Companies announced it is moving toward separating Bausch + Lomb after transferring common shares in an amount equal to approximately 38.6% of the issued and outstanding shares of Bausch + Lomb to an existing wholly-owned unrestricted subsidiary of the company.
- Haag-Streit Opens New Surgical Microscope Production Site in Aesch, Switzerlandhttps://modernod.com/news/haag-streit-opens-new-surgical-microscope-production-site-in-aesch-switzerland/2481047/Haag-Streit announced the opening of a new state-of-the-art microscope production site in Aesch, Switzerland. In September 2021, Haag-Streit decided to reposition and focus solely on ophthalmology and the production and future development of the